Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Journal of Korean Medical Science ; : 26-2020.
Artigo em Inglês | WPRIM | ID: wpr-810960

RESUMO

BACKGROUND: We aimed to investigate whether various immune-related plasma proteins, alone or in combination with conventional clinical risk factors, can predict spontaneous preterm delivery (SPTD) and intra-amniotic infection in women with premature cervical dilation or a short cervix (≤ 25 mm).METHODS: This retrospective study included 80 asymptomatic women with premature cervical dilation (n = 50) or a short cervix (n = 30), who underwent amniocentesis at 17–29 weeks. Amniotic fluid (AF) was cultured, and maternal plasma was assayed for interleukin (IL)-6, matrix metalloproteinase (MMP)-9, tissue inhibitor of metalloproteinases (TIMP)-1, and complements C3a and C5a, using enzyme-linked immunosorbent assay (ELISA) kits. The primary outcome measures were SPTD at < 32 weeks and positive AF cultures.RESULTS: The plasma levels of IL-6, C3a, and C5a, but not of MMP-9 and TIMP-1, were significantly higher in women with SPTD at < 32 weeks than in those who delivered at ≥ 32 weeks. The women who delivered at < 32 weeks had more advanced cervical dilatation, and higher rates of antibiotic and tocolytic administration and were less likely to be given vaginal progesterone than those who delivered at ≥ 32 weeks. Using a stepwise regression analysis, a combined prediction model was developed, which included the plasma IL-6 and C3a levels, and cervical dilatation (area under the curve [AUC], 0.901). The AUC for this model was significantly greater than that for any single variable included in the predictive model. In the univariate analysis, plasma IL-6 level was the only significant predictor of intra-amniotic infection.CONCLUSION: In women with premature cervical dilation or a short cervix, maternal plasma IL-6, C3a, and C5a levels could be useful non-invasive predictors of SPTD at < 32 weeks. A combination of these biomarkers and conventional clinical factors may clearly improve the predictability for SPTD, as compared with the biomarkers alone. An increased plasma level of IL-6 predicted intra-amniotic infection.


Assuntos
Feminino , Humanos , Gravidez , Amniocentese , Líquido Amniótico , Área Sob a Curva , Biomarcadores , Proteínas Sanguíneas , Colo do Útero , Proteínas do Sistema Complemento , Ensaio de Imunoadsorção Enzimática , Interleucina-6 , Interleucinas , Primeira Fase do Trabalho de Parto , Avaliação de Resultados em Cuidados de Saúde , Plasma , Progesterona , Estudos Retrospectivos , Fatores de Risco , Inibidor Tecidual de Metaloproteinase-1 , Inibidores Teciduais de Metaloproteinases
2.
Ginecol. obstet. Méx ; 86(6): 368-373, feb. 2018. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-984446

RESUMO

Resumen OBJETIVO Describir la curva de trabajo de parto en una muestra de pacientes atendidas en el Hospital de Ginecoobstetricia Luis Castelazo Ayala y sentar las bases para redefinir el trabajo de parto normal en la paciente primigesta y, por ende, sus alteraciones. MATERIALES Y MÉTODOS Estudio retrospectivo y descriptivo efectuado en pacientes primigestas sanas con embarazo entre 37 y 41 semanas atendidas para parto eutócico en el Hospital de Ginecoobstetricia Luis Castelazo Ayala del Instituto Mexicano del Seguro Social. Descripción del patrón de progresión del primer estadio de trabajo de parto y de la relación entre el tiempo y la dilatación cervical. RESULTADOS Se incluyeron 370 pacientes primigestas sanas. El trabajo de parto duró, en promedio, 862 minutos (14 horas y 12 minutos). La curva de trabajo de parto graficada fue una pendiente con curva ascendente, con una fase de aceleración desde el inicio de los 4 centímetros de dilatación; a partir de ese momento la duración promedio del trabajo de parto fue de 234 minutos (3 horas y 54 minutos), con un patrón de dilatación de 0.4-0.7 cm por h. CONCLUSIÓN La curva del primer estadio del trabajo de parto de las pacientes estudiadas tuvo un patrón de pendiente ascendente, con una aceleración mayor a partir de los 4 cm de dilatación. Nuestra curva difiere en su morfología de la clásica curva sigmoide de atención de parto de Friedman; a pesar de ello ambas curvas coinciden en que el trabajo de parto entra en su fase activa a los 4 centímetros de dilatación.


Abstract OBJECTIVE To describe the labor curve and the dilation-time ratio of the first stage of labor in a group of patients of the Hospital de Ginecoobstetricia Luis Castelazo Ayala. MATERIALS AND METHODS A retrospective and descriptive study with 370 healthy pregnancy primiparous patients between 37 and 41 gestation weeks admitted in the Obstetrics & Gynecology Hospital "Luis Castelazo Ayala" of the Mexican Social Security Institute. All patients were attended of eutocic delivery without any complication. We reviewed the partogram and the progression of cervical dilation on the first stage of labor. By observing the relationship between time and cervical dilation we described we elaborate a labor curve. RESULTS Labor in its entirety lasted on average 862 minutes (14 hours and 12 minutes). The delivery labor curve graphed was a slope upward curve, with an acceleration phase from 4 centimeters dilated, from that moment the duration of labor average was 234 minutes (3 hours and 54 minutes), with a dilating pattern of 0.4-0.7 cm / h. CONCLUSION The curve of the first stage of labor we studied has an upslope pattern, with an increased acceleration from 4 centimeters of dilation. Our curve differs from the classical sigmoid curve care delivery Dr. Friedman in their basic morphology, however both curves agree that labor enters its active phase in the 4 centimeters of dilation.

3.
Ginecol. obstet. Méx ; 85(3): 125-133, mar. 2017. graf
Artigo em Espanhol | LILACS | ID: biblio-892517

RESUMO

Resumen OBJETIVO: Observar y valorar la eficacia y seguridad en humanos de este nuevo dispositivo para dilatación cervical. MATERIALES Y MÉTODOS: Estudio prospectivo, experimental y de intervención, efectuado en pacientes atendidas entre los meses de enero a diciembre de 2015 en el Hospital General Santa María del Puerto (España) a quienes se realizaron procedimientos diagnósticos y terapéuticos ginecológicos que requirieron dilatación cervical; se utilizó el dispositivo Aqueduct-100®. RESULTADOS: se estudiaron 50 pacientes con edad media de 50 años. Hubo dos grupos de tratamiento: 1) 38 pacientes con dilatación de 5 minutos y 2) 12 con 3 minutos. La indicación más frecuente del procedimiento fue la histeroscopia diagnóstica (44%). El diámetro cervical medio, inicial y posterior al procedimiento, fue de 2.8 y 7.7 mm, respectivamente. La valoración del dispositivo por los especialistas fue de buena a excelente. No se registraron complicaciones relacionadas con el proceso de dilatación cervical. CONCLUSIONES: El dispositivo estudiado es una alternativa sencilla y efectiva para la realización de maniobras de dilatación cervical, previas a diversos procedimientos intrauterinos y endometriales.


Abstract OBJECTIVE: To observe and assess the efficacy and safety of this new cervical dilator device, for the first time in humans. Thus, if the study is successful, raise a second phase through a randomized clinical trial, which purpose shall be to show if there is a superiority of this device with respect to common mechanics dilators. MATERIALS AND METHODS: Prospective, experimental intervention study, in patients undergoing gynecological diagnostic and therapeutic procedures, requiring cervical dilatation, using the Aqueduct - 100®, the Hospital General Santa María del Puerto (Spain). The study included 50 patients who met the criteria for inclusion, in the period January-December 2015. RESULTS: The mean age of the patients was 52.6 years. They were divided into two treatment groups: 38 patients were subjected to a process of expansion of 5 minutes and 12 3-minute processes. The description of the most frequent procedure was the realization of a diagnostic Hysteroscopy (44%). The cervical diameter medium, both initial and subsequent procedure was 2.8 and 7.7 mm, respectively. The valuation of the device by the specialists who used it, ranged between good and excellent rating for all items. There was no complication associated with the process of cervical dilatation with the device. CONCLUSIONS: The Aqueduct - 100® device can be a simple and effective alternative to perform cervical dilatation maneuvers necessary for performing gynecological procedures, intrauterine and endometrial level.

4.
Chinese Journal of Biochemical Pharmaceutics ; (6): 71-73, 2016.
Artigo em Chinês | WPRIM | ID: wpr-486426

RESUMO

Objective To compare the effect of the oxytocin, dinoprostone suppositoriesository and cervical dilation balloon in odinopoeia of late pregnancy.Methods A total of 90 patients with late pregnancy singletons primipara were randomly divided into 3 groups with 30 cases in each group. Patients in the group A were treated by dinoprostone suppositoriesository, patients in the group B were treated by oxytocin, patients in the group C were treated by the cervical dilation balloon, the cervical, childbirth, complications and newborns in the 3 groups were observed and compared. Results Compared with group B and group C, late pregnancy induced labor curative effect in group A was better:cervical Bishop score was higher after intervention 6h and 12 h (P<0.05), and promote cervical mature rate and success rate of induced labor were higher(P<0.05), labor time was shorter (P<0.05).The incidence of delivery complications was lower(P<0.05).Conclusion Dinoprostone suppositories can reduce labor time significantly in the treatment of late pregnancy, and improve the success rate of induced labor, the effect is superior to oxytocin and cervical dilation balloon.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA